Morepen Laboratories Limited (MOREPENLAB) Share Price & AI Investment Analysis
Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-ulcerative, and anti-depressant drugs; and home diagnostic products, such as air purifiers, sphygmomanometers, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermometers, blood glucose monitors,. Track Morepen Laboratories Limited's live NSE:MOREPENLAB share price ₹122.35 (+2.82%), market cap ₹₹67B, P/E 47.8. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for MOREPENLAB — real-time NSE India stock intelligence.


